Lipoprotein(a): the underutilized risk factor for cardiovascular disease

Authors

  • T Z Khan Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom
  • S R Bornstein University Hospital Carl Gustav Carus, Fetscher Street 74, Dresden 01307, Germany
  • M Barbir Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom

DOI:

https://doi.org/10.21542/gcsp.2019.11

Abstract

Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing evidence suggesting that lowering Lp(a) may reduce the risk of cardiovascular events and ameliorate symptoms.

Downloads

Published

2019-05-26

Issue

Section

News and views